Infections: HIV Infections
1. Anonymous LISTEN. Young People as a Force for Change in a World with AIDS. A Collection of Essays on
HIV/AIDS by Young Malaysians. Kuala Lumpur, Malaysia: United Nations Malaysia, 2003.
2. Anonymous The Malaysia Pharmaceuticals and Healthcare Report. Business Monitor International, 2007.
3. Anonymous Consensus report on HIV and AIDS epidemiology in 2004: Malaysia, 2004.
4. Anonymous STD prevalence among antenatal mothers in Kuala Lumpur: Ministry of Health, Malaysia, 2001.
5. Anonymous STD prevalence among sex workers in Kuala Lumpur: Ministry of Health, Malaysia, 2001.
6. Anonymous HIV/AIDS care and treatment for people who inject drugs in Asia and the Pacific: an essential
practice guide. World Health Organization, 2008.
7. Anonymous Women and HIV in the Asia-Pacific Region. A Development Practitioner's Guide. Colombo, Sri
Lanka: UNDP Regional Centre in Colombo, 2008.
8. Anonymous HIV and Men who have Sex with Men in Asia and the Pacific. Geneva: UNAIDS, 2006.
9. Anonymous 2010 UNGASS Country Progress Report: Malaysia, 2010.
10. Anonymous UNGASS Country Progress Report: Malaysia, 2008.
11. Anonymous Malaysian AIDS Council 2008 Annual Report, 2008.
12. Anonymous Management of HIV infected persons at primary health care centres: Ministry of Health,
Malaysia, 2002.
13. Anonymous Scaling Up HIV Testing and Counselling in Asia and the Pacific. Report of a Technical
Consultation. Manila, Philippines: World Health Organization, 2007.
14. Anonymous Mandatory HIV testing for employment of migrant workers in eight countries of South-East Asia:
From discrimination to social dialogue. , 2009.
15. Anonymous Children and AIDS: A stocktaking report. UNICEF, UNAIDS and WHO, 2007.
16. Anonymous HIV and AIDS and the World of Work in ASEAN. International Labour Organization, 2005.
17. Anonymous Guidelines on occupational exposures to human immunodeficiency virus (HIV), Hepatitis B virus
(HBV) and Hepatitis C virus, and recommendations for post exposure prophylaxis (PEP). 2007;.
18. Anonymous Management of HIV infection in pregnant women. 2008;.
19. Anonymous Malaysia 2012. Global AIDS Response. Country Progress Report. 2012;.
20. Anonymous Guidelines on Management of Health Care Workers (HCW) Infected with Human
Immunodeficiency Virus (HIV), Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV). Ministry of Health, Malaysia,
2007.
21. Abu Bakar AM. Bioethics. Malaysian Journal of Pharmacy 2001;1(1):10-15
http://www.cornerstone-msc.net/new_mps/html/publications/journal_of_pharmacy_f.htm.
22. Aceijas C, Stimson GV, Hickman M, et al. Global overview of injecting drug use and HIV infection among
injecting drug users. AIDS 2004;18(17):2295-2303.
23. Adeeba K. Fighting the HIV epidemic in the Islamic world. Lancet 2013;381(9883):2058-2060.
24. Ahmadi K, Reidpath DD, Allotey P, et al. Professionalisation and social attitudes: a protocol for measuring
changes in HIV/AIDS-related stigma among healthcare students. BMJ Open 2013;3(5):10.1136/bmjopen-2013002755. Print 2013
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3669716/.
25. Ahmed SI, Hassali MA, Aziz NA. An assessment of the knowledge, attitudes, and risk perceptions of pharmacy
students regarding HIV/AIDS. Am J Pharm Educ 2009;73(1):15.
26. Akmal MN, Lee CK, Neng EE, et al. Women's attitudes to HIV screening in Hospital Muar antenatal clinic.
Hospital Muar Medical Journal 2003;1(1):15-19
hmmj2003v1n1_Akmal.pdf.
27. Al-Darraji HA, Kamarulzaman A, Altice FL. Isoniazid preventive therapy in correctional facilities: a systematic
review. Int J Tuberc Lung Dis 2012;16(7):871-879.
28. Al-Darraji HA, Razak HA, Ng KP, et al. The Diagnostic Performance of a Single GeneXpert MTB/RIF Assay in an
Intensified Tuberculosis Case Finding Survey among HIV-Infected Prisoners in Malaysia. PLoS One
2013;8(9):e73717.
29. Amadora-Nolasco F, Alburo RE, Aguilar EJ, et al. Knowledge and perception of risk for HIV and condom use
among male injecting drug users in Cebu City, Philippines. Drug Alcohol Rev 2002;21(2):137-143.
30. Anita S, Khatijah MY, Mahamin MY, et al. A cross-sectional study of knowledge, education, risk behaviour,
attitude of HIV/AIDS among factory workers in three states. Kajian hirisan lintang mengenai pengetahuan,
tingkah laku berisiko dan sikap terhadap HIV/AIDS di kalangan pekerja kilang di tiga buah negeri.]. Malaysian
Journal of Public Health Medicine 2004;4(1):40-46
http://www.mjphm.org.my/mjphm/journals/Volume%204%20(1)%20:%202004/40-46.pdf.
31. Anita S, Zahir WM, Sa'iah A, et al. HIV/AIDS knowledge, attitudes and risk behaviours among Orang Asli in
Peninsular Malaysia. Med J Malaysia 2007;62(3):227-233
http://www.e-mjm.org/2007/v62n3/HIV_AIDS.pdf.
32. Ansari AW, Kamarulzaman A, Schmidt RE. Multifaceted Impact of Host C-C Chemokine CCL2 in the ImmunoPathogenesis of HIV-1/ Co-Infection. Front Immunol 2013;4:312.
33. Arijit G, Shalini C. Opportunistic infection associated to HIV/AIDS in Nepal. Med J Malaysia 2007;62(1):88
http://www.e-mjm.org/2007/v62n1/HIV_AIDS.pdf.
34. Asma I, Johari S, Sim BL, et al. How common is intestinal parasitism in HIV-infected patients in Malaysia?
Trop Biomed 2011;28(2):400-410
http://www.msptm.org/files/400_-_410_Asma_I.pdf.
35. Asmal HS, Mustafa M, Abdullah S, et al. Pneumocystis pneumonia among HIV patients in Malaysia. Southeast
Asian J Trop Med Public Health 2009;40(6):1293-1297.
36. Azrul MK. Women and Girls. Confronting HIV and AIDS in Malaysia. Ministry of Health, Malaysia, 2008.
37. Azwa I, Khong SY. Human immunodeficiency virus (HIV) in pregnancy: a review of the guidelines for
preventing mother-to-child transmission in Malaysia. Ann Acad Med Singapore 2012;41(12):587-594.
38. Bachireddy C, Bazazi AR, Kavasery R, et al. Attitudes toward opioid substitution therapy and preincarceration HIV transmission behaviors among HIV-infected prisoners in Malaysia: implications for secondary
prevention. Drug Alcohol Depend 2011;116(1-3):151-157.
39. Bairy KL, Ganaraja B, Indira B, et al. Awareness of post-exposure prophylaxis guidelines against occupational
exposure to HIV in Hospital Sungai Petani. Med J Malaysia 2005;60(1):10-14
http://www.e-mjm.org/2005/v60n1/Occupational_Exposure_to_HIV.pdf.
40. Balkis AK, Zahari CD. HIV prevalence among antenatal mothers in Terengganu. Malaysian Journal of Public
Health Medicine 2003;3(2):48-52
http://www.mjphm.org.my/mjphm/journals/Volume%203%20(2)%20:%202003/48-52.pdf.
41. Barmania S. Malaysia makes progress against HIV, but challenges remain. Lancet 2013;381(9883):2070-2071
http://download.thelancet.com/pdfs/journals/lancet/PIIS0140673613612295.pdf.
42. Bruce RD, Govindasamy S, Sylla L, et al. Case series of buprenorphine injectors in Kuala Lumpur, Malaysia.
Am J Drug Alcohol Abuse 2008;34(4):511-517.
43. Chai HC, Tay ST. Detection of IgM and IgG antibodies to Cryptococcus neoformans proteins in blood donors
and HIV patients with active cryptococcosis. Mycoses 2009;52(2):166-170.
44. Chawarski MC, Mazlan M, Schottenfeld RS. Behavioral drug and HIV risk reduction counseling (BDRC) with
abstinence-contingent take-home buprenorphine: a pilot randomized clinical trial. Drug Alcohol Depend
2008;94(1-3):281-284.
45. Chawarski MC, Mazlan M, Schottenfeld RS. Heroin dependence and HIV infection in Malaysia. Drug Alcohol
Depend 2006;82 Suppl 1:S39-42.
46. Chawarski MC, Vicknasingam B, Mazlan M, et al. Lifetime ATS use and increased HIV risk among not-intreatment opiate injectors in Malaysia. Drug Alcohol Depend 2012;124(1-2):177-180.
47. Chen PC. An analysis of vulnerability to HIV in Papua New Guinea. Pac Health Dialog 2001;8(1):166-175.
48. Chew BH, Cheong AT. Assessing HIV/AIDS knowledge and stigmatizing attitudes among medical students in
Universiti Putra Malaysia. Med J Malaysia 2013;68(1):24-29
http://www.e-mjm.org/2013/v68n1/knowledge-on-HIV-AIDS.pdf.
49. Chew CS, Cherry CL, Kamarulzaman A, et al. A longitudinal study of the effects of ART on plasma chemokine
levels in Malaysian HIV patients. Dis Markers 2011;31(5):303-309.
50. Chitra P, Bakthavatsalam B, Palvannan T. Beta-2 microglobulin as an immunological marker to assess the
progression of human immunodeficiency virus infected patients on highly active antiretroviral therapy. Clin Chim
Acta 2011;412(11-12):1151-1154.
51. Choi BC. An international comparison of women's health issues in the Philippines, Thailand, Malaysia,
Canada, Hong Kong, and Singapore: the CIDA-SEAGEP Study. ScientificWorldJournal 2004;4:989-1006.
52. Choi P, Kavasery R, Desai MM, et al. Prevalence and correlates of community re-entry challenges faced by
HIV-infected male prisoners in Malaysia. Int J STD AIDS 2010;21(6):416-423.
53. Chokephaibulkit K, Kariminia A, Oberdorfer P, et al. Characterizing HIV Manifestations and Treatment
Outcomes of Perinatally Infected Adolescents in Asia. Pediatr Infect Dis J 2013;.
54. Choon SE, Mathew M, Othman BS. Demographic characteristics and prevalence of other sexually transmitted
diseases in HIV-positive patients seen in the Dermatology cum Genitourinary Clinic, Hospital Sultanah Aminah,
Johor Bahru. Med J Malaysia 2000;55(2):174-179
http://www.e-mjm.org/2000/v55n2/Demographic_Characteristics.pdf.
55. Chou CC, Chronister J, Chou CH, et al. Responsibility attribution of HIV infection and coping among injection
drug users in Malaysia. AIDS Care 2013;25(12):1551-1558.
56. Chow WZ, Al-Darraji H, Lee YM, et al. Genome sequences of a novel HIV-1 CRF53_01B identified in Malaysia.
J Virol 2012;86(20):11398-11399.
57. Chow WZ, Ong LY, Razak SH, et al. Molecular diversity of HIV-1 among people who inject drugs in Kuala
Lumpur, Malaysia: massive expansion of circulating recombinant form (CRF) 33_01B and emergence of multiple
unique recombinant clusters. PLoS One 2013;8(5):e62560.
58. Chow YW, Leong CL, Chow HL, et al. Lactic acidosis in HIV patients receiving highly active antiretroviral
therapy. Med J Malaysia 2007;62(1):78-80
http://www.e-mjm.org/2007/v62n1/highly_active_antiretroviral_therapy.pdf.
59. Chuah SY, Leong CK, Pang CW. Dilated common bile duct in opium addicts with and without biliary
symptoms --implication for research in AIDS cholangiopathy. Singapore Med J 2003;44(5):261-267
http://www.sma.org.sg/smj/4405/4405a5.pdf.
60. Copenhaver MM, Tunku N, Ezeabogu I, et al. Adapting an Evidence-Based Intervention Targeting HIVInfected Prisoners in Malaysia. AIDS Res Treat 2011;2011:131045.
61. Das Gupta E, Gun SC, Yong Rafidah AR. Early referral of newly diagnosed rheumatoid arthritis. Family
Physician 2003;12(1):16-18.
62. Degenhardt L, Mathers BM, Wirtz AL, et al. What has been achieved in HIV prevention, treatment and care
for people who inject drugs, 2010-2012? A review of the six highest burden countries. Int J Drug Policy 2013;.
63. Dokubo EK, Kim AA, Le LV, et al. HIV incidence in Asia: a review of available data and assessment of the
epidemic. AIDS Rev 2013;15(2):67-76.
64. Doshi HH. Why should family physicians know about HIV/AIDS. Family Physician 2003;11(1):9-11.
65. Elliott R. Malaysia: damages awarded after mother infected through transfusion during pregnancy. Can HIV
AIDS Policy Law Rev 2003;8(1):77.
66. Fatan Hamamah Y. Kemunculan penyakit berjangkit dan kesannya terhadap manusia di Malaysia. Sari
2005;23:153-168
http://eprints.ukm.my/268/1/sari23%5B10%5D.pdf.
67. Fauziah MN, Anita S, Shaari N, et al. HIV infection among fishermen in Terengganu. Malaysian Journal of
Public Health Medicine 2002;2(1):21-25
http://www.mjphm.org.my/mjphm/journals/Volume%202%20(1)%20:%202002/21-25.pdf.
68. Fauziah MN, Anita S, Sha'ari BN, et al. HIV-associated risk behaviour among drug users at drug rehabilitation
centres. Med J Malaysia 2003;58(2):268-272
http://www.e-mjm.org/2003/v58n2/HIV_Drug_Users.pdf.
69. Fong MY, Wong KT, Rohela M, et al. Unusual manifestation of cutaneous toxoplasmosis in a HIV-positive
patient. Trop Biomed 2010;27(3):447-450
http://msptm.org/files/447_-_450_Fong_MY.pdf.
70. Foong AL, Ng SF, Lee CK. Identifying HIV/AIDS primary care development needs. J Adv Nurs 2005;50(2):134142.
71. Fu JJ, Bazazi AR, Altice FL, et al. Absence of antiretroviral therapy and other risk factors for morbidity and
mortality in Malaysian compulsory drug detention and rehabilitation centers. PLoS One 2012;7(9):e44249.
72. Ghajarieh AB, Kow KY. Addressing men and gender diversity in education: a promising solution to the
HIV/AIDS epidemic. Health Care Women Int 2011;32(4):314-327.
73. Gill JS, Norzuraida Z. HIV risk behaviours among intravenous drug users. Malaysian Journal of Psychiatry
2003;11(1):18-23
http://myais.fsktm.um.edu.my/7592/1/HIV_risk_vol11_no1_(18-23)_2003.pdf.
74. Gulifeiya A, Rahmah M. Nurses awareness and attitude towards HIV/AIDS and universal precautions: a crosssectional study in UKMMC. Jurnal Kesihatan Masyarakat 2008;14(2):36-45
http://journalarticle.ukm.my/4612/1/Vol14(1)-aniza.pdf.
75. Gurunathan A. An Epidemiological Evaluation Of TB/HIV - AIDS Status In Malaysia: Clinical And
Microbiological Outcomes Of The Diseases. 2004;.
76. Gurunathan A, Ibrahim P, Syed Sulaiman SA, et al. The Epidemiological Status Of TB/HIV-AIDS Co-Infected
Individuals In Malaysia. Malaysian Journal of Pharmaceutical Sciences 2004;2(2):38-38
http://myais.fsktm.um.edu.my/6878/1/the_epide_vol2_no2_(38)2004.PDF.
77. Haliza MR, Pataki-Schweizer KJ. HIV/AIDS: The Realities, The Challenges. Kuala Lumpur: Ministry of Health,
Malaysia, 2002.
78. Hamid MZ, Aziz NA, Zulkifli ZS, et al. Clinical features and risk factors for HIV encephalopathy in children.
Southeast Asian J Trop Med Public Health 2008;39(2):266-272.
79. Hasan SS, Keong SC, Choong CL, et al. Patient-reported adverse drug reactions and drug-drug interactions: a
cross-sectional study on Malaysian HIV/AIDS patients. Med Princ Pract 2011;20(3):265-270.
80. Hasan SS, See CK, Choong CL, et al. Reasons, perceived efficacy, and factors associated with complementary
and alternative medicine use among Malaysian patients with HIV/AIDS. J Altern Complement Med
2010;16(11):1171-1176.
81. Hasanah CI, Zaliha AR, Mahiran M. Factors influencing the quality of life in patients with HIV in Malaysia.
Qual Life Res 2011;20(1):91-100.
82. Hasnah B, Mohd Hatta M. Knowledge, attitude and practice of prevention towards HIV/AIDS amongst health
personnel in Tapah Hospital , Perak, 1996. Jurnal Kesihatan Masyarakat 2006;12(1).
83. Hasnah B. Knowledge, attitude and practice of prevention towards HIV/AIDS amongst health personnel in
Tapah Hospital, Perak. 9999;.
84. Hejazi N, Rajikan R, Kwok Choong LC, et al. Metabolic abnormalities in adult HIV infected population on
antiretroviral medication in Malaysia: a cross-sectional survey. BMC Public Health 2013;13(1):758.
85. HIV-CAUSAL Collaboration. Impact of antiretroviral therapy on tuberculosis incidence among HIV-positive
patients in high-income countries. Clin Infect Dis 2012;54(9):1364-1372.
86. HIV-CAUSAL Collaboration, Cain LE, Logan R, et al. When to initiate combined antiretroviral therapy to
reduce mortality and AIDS-defining illness in HIV-infected persons in developed countries: an observational
study. Ann Intern Med 2011;154(8):509-515.
87. HIV-CAUSAL Collaboration, Ray M, Logan R, et al. The effect of combined antiretroviral therapy on the
overall mortality of HIV-infected individuals. AIDS 2010;24(1):123-137.
88. Huang M. HIV among fishers: vulnerability of their partners. In: Anonymous World Fish Center, 2002.
89. Huang M, Hussein H. The HIV/AIDS epidemic country paper: Malaysia. AIDS Educ Prev 2004;16(3 Suppl
A):100-109.
90. Ibrahim N, Rampal L, Jamil Z, et al. Effectiveness of peer-led education on knowledge, attitude and risk
behavior practices related to HIV among students at a Malaysian public university--a randomized controlled trial.
Prev Med 2012;55(5):505-510.
91. Iqbal A, Lim YA, Surin J, et al. High diversity of Cryptosporidium subgenotypes identified in Malaysian
HIV/AIDS individuals targeting gp60 gene. PLoS One 2012;7(2):e31139.
92. Isa WY, Daud KM. Distal renal tubular acidosis in HIV/AIDS patient. Intern Med 2011;50(16):1765-1768.
93. Ismail I, Bulgiba A. Determinants of unsuccessful tuberculosis treatment outcomes in Malaysian HIV-infected
patients. Prev Med 2013;57 Suppl:S27-30.
94. Ismail I, Bulgiba A. Predictors of Death during Tuberculosis Treatment in TB/HIV Co-Infected Patients in
Malaysia. PLoS One 2013;8(8):e73250.
95. Jahanfar S, Lim AW, Loh MA, et al. Improvements of knowledge and perception towards HIV/AIDS among
secondary school students after two hours talk. Med J Malaysia 2008;63(4):288-292
http://www.e-mjm.org/2008/v63n4/HIV_AIDs.pdf.
96. Jahanfar S, Lye MS, Rampal L. A randomised controlled trial of peer-adult-led intervention on improvement
of knowledge, attitudes and behaviour of university students regarding HIV/AIDS in Malaysia. Singapore Med J
2009;50(2):173-180
http://smj.sma.org.sg/5002/5002a9.pdf.
97. Jamaiah I, Rohela M, Tok EL, et al. Pneumocystis carinii (jirovecii) pneumonia (PCP): the most common
opportunistic infection observed in HIV/AIDS cases at the University Malaya Medical Centre, Kuala Lumpur,
Malaysia. Southeast Asian J Trop Med Public Health 2012;43(4):825-831.
98. Jamalluddin AR. Review of pulmonary tuberculosis patients with positive culture in Kuala Terengganu, 19982001. International Medical Journal (IIUM) 2003;2(2)
http://www.e-imj.com/Vol2-No2/Vol2-No2-B13.htm.
99. Japaraj RP, Sivalingam N. The prevalence of HIV positive antenatal mothers in a routine screening
programme in two states. Med J Malaysia 2001;56(2):180-185
http://www.e-mjm.org/2001/v56n2/HIV_positive_antenatal_mothers.pdf.
100. Jarmin R, Alwi RI, Shaharuddin S, et al. Common bile duct perforation due to tuberculosis: a case report.
Asian J Surg 2004;27(4):342-344.
101. Jasvindar K. Knowledge of HIV transmission among Malaysians: a population based study. Journal of Health
Management 2012;10(2):10-19
http://www.ihm.moh.gov.my/images/files/PENERBITAN-IPK-2012/Journal/Journal-of-HealthManagement_01122012_Vol-10-No.2_2012.pdf.
102. Jayaram G, Chew MT. Fine needle aspiration cytology of lymph nodes in HIV-infected individuals. Acta Cytol
2000;44(6):960-966.
103. Jing W. A retrospective survey of mucocutaneous manifestations of HIV infection in Malaysia: analysis of
182 cases. J Dermatol 2000;27(4):225-232.
104. Juita G, Osman A. Drug addiction and HIV infection amongst male in Malaysia, 1994. Jurnal Kesihatan
Masyarakat 2006;12(1).
105. Kamal Solhaimi F, Ng CJ. "If you don't try, you wouldn't know right?" Exploring adolescent sexuality, sexual
risk-taking behaviour and HIV risk. Malaysian Journal of Social Policy and Society 2005;2:146-166.
106. Kamarulzaman A. Impact of HIV prevention programs on drug users in Malaysia. J Acquir Immune Defic
Syndr 2009;52 Suppl 1:S17-9.
107. Kamarulzaman A. Taking stock of two decades of the HIV/AIDS epidemic in Malaysia. Med J Malaysia
2005;60(1):1-4
http://www.e-mjm.org/2005/v60n1/Hiv_Aids_Epidemic.pdf.
108. Kamarulzaman A, Razali K. Malaysia. In: Beyrer C, ed. , 2008:481-500.
109. Kamarulzaman A, Saifuddeen SM. Islam and harm reduction. Int J Drug Policy 2010;21(2):115-118.
110. Kanter J, Koh C, Razali K, et al. Risk behaviour and HIV prevalence among men who have sex with men in a
multiethnic society: a venue-based study in Kuala Lumpur, Malaysia. Int J STD AIDS 2011;22(1):30-37.
111. Kenali MS, Fadzilah I, Maizaton AA, et al. Concurrent mycobacterial infection and non-Hodgkin's lymphoma
at the same site in an AIDS patient. Med J Malaysia 2004;59(1):108-111
http://www.e-mjm.org/2004/v59n1/AIDS_Patient.pdf.
112. Ketter A. Malaysia: Judge refuses to reduce sentence on account of HIV. HIV AIDS Policy Law Rev
2005;10(1):62-63.
113. Khairy-Shamel ST, Shatriah I, Adil H, et al. Orbital rhabdomyosarcoma in an HIV positive child. Orbit
2008;27(5):388-390.
114. Khan SA, Moorthy J, Omar H, et al. People living with HIV/AIDS (PLWHA) and HIV/AIDS associated oral
lesions; a study in Malaysia. BMC Public Health 2012;12:850-2458-12-850.
115. Khebir BV, Adam MA, Daud AR, et al. Premarital HIV screening in Johor--(2002-2004). Med J Malaysia
2007;62(1):19-22
http://www.e-mjm.org/2007/v62n1/Premarital_HIV_screening.pdf.
116. Khoo SB. Integrating palliative medicine into family medicine. Family Physician 2003;12(1):19-21.
117. Koh KC, Teh JR, Khan SA. Beliefs and attitudes of medical students from public and private universities in
Malaysia towards individuals with HIV/AIDS. ScientificWorldJournal 2013;2013:462826
http://downloads.hindawi.com/journals/tswj/2013/462826.pdf.
118. Koh KC, Kamarulzaman A. Profiles of men-who-have-sex-with-men seeking anonymous voluntary HIV
counseling and testing at a community-based centre in Malaysia. Med J Malaysia 2011;66(5):491-494
http://www.e-mjm.org/2011/v66n5/HIV.pdf.
119. Koh KC, Lee WY, Eh ZW, et al. Efavirenz does not cause false-positive urine cannabis test in HIV-infected
patients on Highly Active Anti-Retroviral Therapy. Med J Malaysia 2013;68(3):249-252
http://www.e-mjm.org/2013/v68n3/Efavirenz.pdf.
120. Kooi ES, Mahayidin M. Pulmonary Tuberculosis in HIV Infection : The Relationship of the Radiographic
Appearance to CD4 T-Lymphocytes Count. Malays J Med Sci 2001;8(1):34-40
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3433962/pdf/mjms-8-1-034.pdf;
http://ernd.usm.my/journal/journal/MJMS-8-1034.pdf.
121. Koon Teh Y. HIV-related needs for safety among male-to-female transsexuals (mak nyah) in Malaysia.
SAHARA J 2008;5(4):178-185.
122. Kwa SK. Test your knowledge. What are the chances of contracting HIV during an unprotected heterosexual
encounter? Family Physician 2001;11(3):39-39.
123. Labarga P. Cytomegalovirus, Aging, and HIV: A Perfect Storm. AIDS Rev 2013;15(3):189-190.
124. Lau KA, Wang B, Kamarulzaman A, et al. Near full-length sequence analysis of a Unique CRF01_AE/B
recombinant from Kuala Lumpur, Malaysia. AIDS Res Hum Retroviruses 2007;23(9):1139-1145.
125. Lau KA, Wang B, Kamarulzaman A, et al. Continuous crossover(s) events of HIV-1 CRF01_AE and B subtype
strains in Malaysia: evidence of rapid and extensive HIV-1 evolution in the region. Curr HIV Res 2008;6(2):108116.
126. Lau KA, Wang B, Miranda-Saksena M, et al. Evidence for possible biological advantages of the newly
emerging HIV-1 circulating recombinant form from Malaysia - CRF33_01B in comparison to its progenitors CRF01_AE and subtype B. Curr HIV Res 2010;8(3):259-271.
127. Lee CE, Sri Ponnampalavanar S, Syed Omar SF, et al. Evaluation of the dried blood spot (DBS) collection
method as a tool for detection of HIV Ag/Ab, HBsAg, anti-HBs and anti-HCV in a Malaysian tertiary referral
hospital. Ann Acad Med Singapore 2011;40(10):448-453.
128. Lee CK. Changing approaches in HIV testing. Med J Malaysia 2007;62(1):1-2
http://www.e-mjm.org/2007/v62n1/HIV_Testing.pdf.
129. Lee LK, Chen PC, Lee KK, et al. Premarital sexual intercourse among adolescents in Malaysia: a crosssectional Malaysian school survey. Singapore Med J 2006;47(6):476-481
http://www.sma.org.sg/smj/4706/4706a2.pdf.
130. Leng LK, Pancharoen C, Bunupuradah T, et al. Regression of a cervical spinal mass following highly active
antiretroviral therapy (HAART) in child with advanced human immunodeficiency virus (HIV) disease. J Med Assoc
Thai 2007;90(9):1937-1942.
131. Leow YM. By youth, for youth. The Star 2007;.
132. Lian YL, Heng BS, Nissapatorn V, et al. AIDS-defining illnesses: a comparison between before and after
commencement of highly active antiretroviral therapy (HAART). Curr HIV Res 2007;5(5):484-489.
133. Lim YAL, Asma I, Surin J, et al. First genetic classification of Cryptosporidium and Giardia from HIV/AIDS
patients in Malaysia. Infect Genet Evol 2011;11(5):968-974
http://ac.els-cdn.com/S1567134811000888/1-s2.0-S1567134811000888-main.pdf?_tid=c902cc34-5fad-11e3b507-00000aacb361&acdnat=1386468755_faf9948c01d3a752f3e88a3a78c47ffc.
134. Lim A, Tan D, Price P, et al. Proportions of circulating T cells with a regulatory cell phenotype increase with
HIV-associated immune activation and remain high on antiretroviral therapy. AIDS 2007;21(12):1525-1534.
135. Lim SH, Guadamuz TE, Wei C, et al. Factors associated with unprotected receptive anal intercourse with
internal ejaculation among men who have sex with men in a large Internet sample from Asia. AIDS Behav
2012;16(7):1979-1987.
136. Lim YA, Rohela M, Sim BL, et al. Prevalence of cryptosporidiosis in HIV-infected patients in Kajang Hospital,
Selangor. Southeast Asian J Trop Med Public Health 2005;36 Suppl 4:30-33.
137. Lono A, Kumar S, Chye TT. Detection of microsporidia in local HIV-positive population in Malaysia. Trans R
Soc Trop Med Hyg 2011;105(7):409-413.
138. Lopez M. A Multi-Step Pace Towards a Cure for HIV: Kick, Kill, and Contain. AIDS Rev 2013;15(3):190-191.
139. Low WY, Ng CJ, Kamal Solhaimi F, et al. Sexual issues: let's hear it from the Malaysian boys. Journal of Men's
Health & Gender 2007;4(3):283-291.
140. Low WY, Ng CJ, Kamal Solhaimi F, et al. Sexual issues: let's hear it from the Malaysian boys. Journal of Men's
Health & Gender 2007;4(3):283-291.
141. Lua PL, Norhayati M, Ahmad Kashfi A. HRQoL profile and psychometric properties assessment of caregiver
quality of life instrument among HIV/AIDS family caregivers in Terengganu. Malaysian Journal of Psychiatry
2013;22(1):9-21 http://mjpsychiatry.org/index.php/mjp/article/viewFile/231/173.
142. Lua PL, Norhayati M. Mental health-related experiences and challenges of informal HIV/AIDS caregivers: a
brief review and analysis. ASEAN Journal of Psychiatry 2012;13(2):197-217
www.aseanjournalofpsychiatry.org/index.php/aseanjournalofpsychiatry/article/viewFile/111/96.
143. Lubis R, Bulgiba A, Kamarulzaman A, et al. Predictors of death in Malaysian HIV-infected patients on antiretroviral therapy. Prev Med 2013;57 Suppl:S54-6.
144. Manan MM, Ali SM, Khan MA, et al. Review on the demographic and social impact of methadonemedication therapy on Malaysian patients. Pak J Pharm Sci 2013;26(4):841-846.
145. Mapanga KG, Mapanga MB. A modern African perspective on the role of the clinical nurse specialist. Clin
Nurse Spec 2008;22(5):226-230.
146. Martin A, Moore C, Mallon PW, et al. Bone mineral density in HIV participants randomized to raltegravir
and lopinavir/ritonavir compared with standard Second Line therapy. AIDS 2013;.
147. Marzuki OA, Fauzi AR, Ayoub S, et al. Prevalence and risk factors of anti-tuberculosis drug-induced hepatitis
in Malaysia. Singapore Med J 2008;49(9):688-693
http://smj.sma.org.sg/4909/4909a5.pdf.
148. Mazlan M, Schottenfeld RS, Chawarski MC. New challenges and opportunities in managing substance abuse
in Malaysia. Drug Alcohol Rev 2006;25(5):473-478.
149. McCormick A, Sultan J. Liver transplantation--patient selection and timing. Med J Malaysia 2005;60 Suppl
B:83-87.
150. Mendelsohn JB, Schilperoord M, Spiegel P, et al. Is Forced Migration a Barrier to Treatment Success? Similar
HIV Treatment Outcomes Among Refugees and a Surrounding Host Community in Kuala Lumpur, Malaysia. AIDS
Behav 2013;.
151. Menon A, Adeeba K. Is it HIV? a handbook for health care providers. Australasian Society for HIV Medicine,
2009.
152. Mesquita F, Jacka D, Ricard D, et al. Accelerating harm reduction interventions to confront the HIV
epidemic in the Western Pacific and Asia: the role of WHO (WPRO). Harm Reduct J 2008;5:26-7517-5-26.
153. Mimi Iznita MI. The role of religion in coping with HIV among HIV-positive patients in Malaysia. 2004;:64103.
154. Mohamad S, Deris ZZ, Yusoff NK, et al. Assessing subtypes and drug resistance mutations among HIV-1
infected children who failed antiretroviral therapy in Kelantan, Malaysia. Braz J Infect Dis 2012;16(3):284-288.
155. Mohammad Z, Naing NN. Characteristics of HIV-infected tuberculosis patients in Kota Bharu Hospital,
Kelantan from 1998 to 2001. Southeast Asian J Trop Med Public Health 2004;35(1):140-143.
156. Mohammad Z, Naing NN, Salleh R, et al. A preliminary study of the influence of HIV infection in the
transmission of tuberculosis. Southeast Asian J Trop Med Public Health 2002;33(1):92-98.
157. Mohd NM, Yeo J, Huang MS, et al. Nutritional status of children living with HIV and receiving antiretroviral
(ARV) medication in the Klang Valley, Malaysia. Malays J Nutr 2011;17(1):19-30.
158. Mondal M, Shitan M. Factors affecting the HIV/AIDS epidemic: an ecological analysis of global data. Afr
Health Sci 2013;13(2):301-310.
159. Muhammad Muhsin Z, Bae WH, Nor Zuraida Z, et al. Psychiatric and substance abuse comorbidity among
HIV seropositive and HIV seronegative prisoners in Malaysia. Am J Drug Alcohol Abuse 2010;36(1):31-38.
160. Musa MN. Rumah Solehah-Malaysia: Half way home for women and children with HIV/AIDS. Bangladesh
Journal of Medical Science 2009;8(1-2):29-32
http://www.banglajol.info/index.php/BJMS/article/view/3187/2682.
161. Naing L, Rusli N, Razlan M. The prevalence of, and factors related to, compliance with glove utilization
among nurses in Hospital Universiti Sains Malaysia. Southeast Asian J Trop Med Public Health 2001;32(3):636642
http://www.tm.mahidol.ac.th/seameo/2001_32_3/34-2701.pdf.
162. Naing C, Mak JW, Maung M, et al. Meta-analysis: the association between HIV infection and
extrapulmonary tuberculosis. Lung 2013;191(1):27-34.
163. Naing CM, Hakim M, Yee DA, et al. HIV/AIDS-related knowledge, attitudes and perceptions: a crosssectional household survey. Southeast Asian J Trop Med Public Health 2010;41(4):952-960.
164. Narwani H, Naing NN. Comparison of socio-economic and demographic characteristics of HIV and HIVinfected tuberculosis patients in Kota Bharu Hospital, Kelantan. Jurnal Kesihatan Masyarakat 2004;10:38-40
http://journalarticle.ukm.my/4438/1/2004-02nizam.pdf.
165. Nasir MTM, Yeo J, Huang MSL, et al. Nutritional status and the use of protease inhibitors among Hivinfected children in Klang Valley, Malaysia. Malaysian Journal of Medicine and Health Sciences 2011;7(2):73-79
http://medic.upm.edu.my/images/stories/journal/VOL7NO2_JUNE2011.pdf.
166. Ng CJ, Kamal SF. Bridging the gap between adolescent sexuality and HIV risk: the urban Malaysian
perspective. Singapore Med J 2006;47(6):482-490
http://www.sma.org.sg/smj/4706/4706a3.pdf.
167. Ng KT, Ong LY, Lim SH, et al. Evolutionary history of HIV-1 subtype B and CRF01_AE transmission clusters
among men who have sex with men (MSM) in Kuala Lumpur, Malaysia. PLoS One 2013;8(6):e67286.
168. Ng KT, Ong LY, Takebe Y, et al. Genome sequence of a novel HIV-1 circulating recombinant form 54_01B
from Malaysia. J Virol 2012;86(20):11405-11406.
169. Nimir AR, Osman E, Ibrahim IA, et al. Is it toxoplasma encephalitis, HIV encephalopathy or brain
tuberculoma? BMJ Case Rep 2013;2013:10.1136/bcr-2013-008803.
170. Nissapatorn V. Lessons learned about opportunistic infections in southeast Asia. Southeast Asian J Trop
Med Public Health 2008;39(4):625-641.
171. Nissapatorn V. Toxoplasmosis in HIV/AIDS: a living legacy. Southeast Asian J Trop Med Public Health
2009;40(6):1158-1178.
172. Nissapatorn V, Kamarulzaman A, Init I, et al. Seroepidemiology of toxoplasmosis among HIV-infected
patients and healthy blood donors. Med J Malaysia 2002;57(3):304-310
http://www.e-mjm.org/2002/v57n3/Seroepidemiology.pdf.
173. Nissapatorn V, Kuppusamy I, Init I, et al. Pulmonary tuberculosis in HIV/AIDS Patients. Trop Biomed
2002;19(1):49-53.
174. Nissapatorn V, Kuppusamy I, Sim BL, et al. Tuberculosis in HIV/AIDS patients: a Malaysian experience.
Southeast Asian J Trop Med Public Health 2005;36(4):946-953.
175. Nissapatorn V, Lee CKC, Khairul AA. Impact of pulmonary opportunistic infections among AIDS patients in
General Hospital Kuala Lumpur, Kuala Lumpur, 2001. Trop Biomed 2001;18(2):117-121.
176. Nissapatorn V, Lee CKC, Khairul AA. The prevalence of AIDS-related skin diseases in Hospital Kuala Lumpur.
Trop Biomed 2002;19(1):55-60.
177. Nissapatorn V, Lee C, Fatt QK, et al. AIDS-related opportunistic infections in Hospital Kuala Lumpur. Jpn J
Infect Dis 2003;56(5-6):187-192.
178. Nissapatorn V, Lee C, Ithoi I, et al. Tuberculosis in AIDS patients. Malays J Med Sci 2003;10(1):60-64
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3557111/pdf/mjms-10-1-060.pdf.
179. Nissapatorn V, Lee C, Quek KF, et al. Toxoplasmosis in HIV/AIDS patients: a current situation. Jpn J Infect Dis
2004;57(4):160-165.
180. Nissapatorn V, Lee CK, Cho SM, et al. Toxoplasmosis in HIV/AIDS patients in Malaysia. Southeast Asian J
Trop Med Public Health 2003;34 Suppl 2:80-85.
181. Nissapatorn V, Lee CK, Khairul AA. Seroprevalence of toxoplasmosis among AIDS patients in Hospital Kuala
Lumpur, 2001. Singapore Med J 2003;44(4):194-196
http://www.sma.org.sg/smj/4404/4404a4.pdf.
182. Nissapatorn V, Lee CK, Rohela M, et al. Spectrum of opportunistic infections among HIV-infected patients in
Malaysia. Southeast Asian J Trop Med Public Health 2004;35 Suppl 2:26-32.
183. Nissapatorn V, Sawangjaroen N. Parasitic infections in HIV infected individuals: diagnostic & therapeutic
challenges. Indian J Med Res 2011;134(6):878-897.
184. Niza S, Aishah A, Mohd Aznan MA, et al. Social and HIV/AIDS risk behaviours in a fishing community.
International Journal of Humanities and Social Science 2011;1(21):251-257
http://www.ijhssnet.com/journals/Vol_1_No_21_Special_Issue_December_2011/25.pdf.
185. Nong S, Liang J. Bone marrow Penicillium marneffei infection in acquired immunodeficiency syndrome
patients: report of 35 cases. Trop Biomed 2013;30(1):89-91.
186. Nor Hayati S, Sahlawati M, Suresh Kumar C, et al. A retrospective review on successful management of
Penicillium marneffei infections in patients with advanced HIV in Hospital Sungai Buloh. Med J Malaysia
2012;67(1):66-70
http://www.e-mjm.org/2012/v67n1/Penicillium_marneffei.pdf.
187. Normala I, Zubaidah J, Nik Shaliza H, et al. Sound HIV knowledge and common misconceptions about HIV
among university students. Malaysian Journal of Medicine and Health Sciences 2013;9(1):29-34
http://medic.upm.edu.my/images/stories/journal/VOL9NO1_JANUARI2013.pdf;;;.
188. Norzila Z. Validity and Reliability of the Malay Translated Medical Outcomes Study-HIV Health Survey (MOSHIV) Among HIV Patients. A Multicentre Study. 2007;.
189. Nurfahzura MJ, Hanizasurana H, Zunaina E, et al. Successful treatment of syphilitic uveitis in HIV-positive
patients. Clin Ophthalmol 2013;7:1651-1654.
190. Ong HC, Soo KL. Backcalculation of HIV infection rates in Malaysia. Med J Malaysia 2006;61(5):616-620
http://www.e-mjm.org/2006/v61n5/HIV_Infection_Malaysia.pdf.
191. Ong LY, Razak SN, Lee YM, et al. Molecular diversity of HIV-1 and surveillance of transmitted drug resistance
variants among treatment Naive patients, 5 years after active introduction of HAART in Kuala Lumpur, Malaysia.
J Med Virol 2013;.
192. Osteria TS. Adolescent Reproductive Health in Southeast Asia: Malaysia. Manila: UNESCO, 2008.
193. Othman N, Yip CW, Intan HI, et al. An abdominal mass owing to Penicillium marneffei in an HIV-infected 7year-old boy: case report. Ann Trop Paediatr 2006;26(3):259-262.
194. Oyomopito RA, Li PC, Sungkanuparph S, et al. Evaluating immunologic response and clinical deterioration in
treatment-naive patients initiating first-line therapies infected with HIV-1 CRF01_AE and subtype B. J Acquir
Immune Defic Syndr 2013;62(3):293-300.
195. Poynard T. Management of patients coinfected by HCV and HIV. Med J Malaysia 2005;60 Suppl B:70-71.
196. Prameela KK. HIV transmission through breastmilk: the science behind the understanding of current trends
and future research. Med J Malaysia 2012;67(6):644-651
http://www.e-mjm.org/2012/v67n6/HIV-transmission-through-breastmilk.pdf.
197. Purcell DF, Elliott JH, Ross AL, et al. Towards an HIV Cure: science and debate from the International AIDS
Society 2013 symposium. Retrovirology 2013;10(1):134.
198. Rahman M, Ken W, Norzuriza M, et al. Scenerio of HIV patients reported to University Kebangsaan Medical
Centre during 2006-2009. Bangladesh Journal of Medical Science 2011;10(1):21-28
http://www.banglajol.info/index.php/BJMS/article/view/7315/5518.
199. Razali SM. Drug substitution therapy: a new approach in preventing the spread of HIV/AIDS in Malaysia.
Trop Doct 2008;38(2):109-110.
200. Reid G, Kamarulzaman A, Sran SK. Malaysia and harm reduction: the challenges and responses. Int J Drug
Policy 2007;18(2):136-140.
201. Rohani A, Nasir AA. Sexually transmitted infections (including hiv infection) care management using the
"modified syndromic approach" in Malaysia. Malaysian Journal of Public Health Medicine 2002;2(2):52-57
http://www.mjphm.org.my/mjphm/journals/Volume%202%20(2)%20:%202002/52-57.pdf.
202. Root R. "Mixing" as an ethnoetiology of HIV/AIDS in Malaysia's multinational factories. Med Anthropol Q
2006;20(3):321-344.
203. Root R. "Controlling ourselves, by ourselves": risk assemblages on Malaysia's assembly lines. Med
Anthropol 2008;27(4):405-434.
204. Roshan TM, Rosline H, Ahmed SA, et al. Response rate of Malaysian blood donors with reactive screening
test to transfusion medicine unit calls. Southeast Asian J Trop Med Public Health 2009;40(6):1315-1321.
205. Rozaidah T. Malaysia. In: Itoh S, ed. Tokyo: Japan Center for International Exchange, 2006:195-206.
206. Rozina R, Lekhraj R, Lye MS, et al. Knowledge, attitude and practice related to HIV/AIDS among students in
a local university (2007). Malaysian Journal of Medicine and Health Sciences 2009;5(2):27-41
http://medic.upm.edu.my/images/stories/journal/VOL5NO2_JUNE2009.pdf.
207. Saddki N, Noor MM, Norbanee TH, et al. Validity and reliability of the Malay version of WHOQOL-HIV BREF
in patients with HIV infection. AIDS Care 2009;21(10):1271-1278.
208. Sarnon N, Baba I, Jusojf K, et al. Psychosocial reactions of injecting drug users'(IDU) towards needle syringe
exchange program in Malaysia. World Applied Sciences Journal 2011;12:80-84
http://www.scopus.com/inward/record.url?eid=2-s2.083155166489&partnerID=40&md5=c9c78ebc5869f0d654eee5d052ec16a6.
209. Schottenfeld RS, Chawarski MC, Mahmud M. Maintenance treatment with buprenorphine and naltrexone
for heroin dependence in Malaysia: a randomised, double-blind, placebo-controlled trial. Lancet
2008;371(9631):2192-2200.
210. Shamilah H, Lokman Hakim.S., Noor Azian MY, et al. Seroprevalence of Toxoplasma gondii antibodies in HIV
positive and negative patients using the immunofluorescence antibody test (IFAT) methods. Trop Biomed
2001;18(2):137-141.
211. Shankar EM, Vignesh R, Ellegard R, et al. HIV-Mycobacterium tuberculosis co-infection: A 'danger-couple
model' of disease pathogenesis. Pathog Dis 2013;.
212. Sharifa Ezat WP, Mohammad J, Jamsiah M, et al. Knowledge, attitude and practice about HIV/AIDS and its
influencing factors among pregnant mothers in west of Sabah, Malaysia. Malaysian Journal of Public Health
Medicine 2012;12(2):15-23
http://www.mjphm.org.my/mjphm/journals/Volume%2012:2/202KNOWLEDGE,%20ATTITUDE%20AND%20PRACTICE%20ABOUT%20HIVAIDS%20AND%20ITS%20INFLUENCING%2
0FACTORS%20AMONG%20PREGNANT%20MOTHERS%20IN%20WEST%20OF%20SABAH,%20MALAYSIA.pdf.
213. Shetty P. Adeeba Kamarulzaman: fighting HIV/AIDS in Malaysia. Lancet 2013;381(9883):20736736(13)61231-3
http://download.thelancet.com/pdfs/journals/lancet/PIIS0140673613612313.pdf.
214. Silverman JG, Decker MR, McCauley HL, Mack KP. A Regional Assessment of Sex Trafficking and STI/HIV in
Southeast Asia: Connections between Sexual Exploitation, Violence and Sexual Risk. UNDP Regional Centre in
Colombo, 2009.
215. Siti Norazah Z, Wong YL. Knowledge, attitudes and beliefs related to HIV/AIDS among adolescents in
Malaysia. Med J Malaysia 2002;57(1):3-23
http://www.e-mjm.org/2002/v57n1/Knowledge_Attitudes_beliefs_on_HIV_AIDS.pdf.
216. Siti Norazah Z, Huang MSL, Low WY, Wong YL. Impact of HIV on People Living with HIV, Their Families and
Community in Malaysia. Kuala Lumpur, Malaysia: United Nations Development Programme, 2007.
217. Song A, Richters J, Crawford J, et al. HIV and sexual health knowledge and sexual experience among
Australian-born and overseas-born students in Sydney. J Adolesc Health 2005;37(3):243
.
218. Subha ST, Raman R. Nocardia infection of the mastoid in an immunocompromised patient. Med J Malaysia
2004;59(5):688-689
http://www.e-mjm.org/2004/v59n5/Nocardia_Infection.pdf.
219. Sujak SL, Abdul-Kadir R, Omar R. Self-disclosure of HIV status: perception of malaysian HIV-positive subjects
towards attitude of dental personnel in providing oral care. Asia Pac J Public Health 2005;17(1):15-18.
220. Sumatoh HR, Oliver BG, Kumar M, et al. Mycobacterial antibody levels and immune restoration disease in
HIV patients treated in South East Asia. Biomark Med 2011;5(6):847-853.
221. Sungkanuparph S, Oyomopito R, Sirivichayakul S, et al. HIV-1 drug resistance mutations among
antiretroviral-naive HIV-1-infected patients in Asia: results from the TREAT Asia Studies to Evaluate ResistanceMonitoring Study. Clin Infect Dis 2011;52(8):1053-1057.
222. Suresh N, Balasingam V, Noor Zurani, Md Haris Robson. The transition to harm reduction: understanding
the role of non-governmental organisations in Malaysia. Int J Drug Policy 2011;22(4):311-317.
223. Syed Wasif G, Syed Azhar SS. Chronic infections and management setting in drug addicts of MMT program
in Pinang, Malaysia. International Journal of Collaborative Research on Internal Medicine & Public Health
2009;1(2):48-54
http://iomcworld.com/ijcrimph/files/v01-n02-02.pdf.
224. Syed IA, Syed Sulaiman SA, Hassali MA, et al. Assessing HIV and AIDS treatment safety and health-related
quality of life among cohort of Malaysian patients: a discussion on methodological approach. Health Expect
2013;.
225. Tan DB, Yong YK, Tan HY, et al. Immunological profiles of immune restoration disease presenting as
mycobacterial lymphadenitis and cryptococcal meningitis. HIV Med 2008;9(5):307-316.
226. Tan TC, Ong SC, Suresh KG. Genetic variability of Blastocystis sp. isolates obtained from cancer and
HIV/AIDS patients. Parasitol Res 2009;105(5):1283-1286.
227. Tay ST, Rohani MY, Hoo TS, et al. Epidemiology of cryptococcosis in Malaysia. Mycoses 2010;53(6):509-514.
228. Tayib S, van Wijk L, Denny L. Gestational trophoblastic neoplasia and human immunodeficiency virus
infection: a 10-year review. Int J Gynecol Cancer 2011;21(9):1684-1691.
229. Tee KK, Kamarulzaman A, Ng KP. Short communication: low prevalence of genotypic drug resistance
mutations among antiretroviral-naive HIV type 1 patients in Malaysia. AIDS Res Hum Retroviruses
2006;22(2):121-124.
230. Tee KK, Kamarulzaman A, Ng KP. Prevalence and pattern of drug resistance mutations among antiretroviraltreated HIV-1 patients with suboptimal virological response in Malaysia. Med Microbiol Immunol
2006;195(2):107-112.
231. Tee KK, Li XJ, Nohtomi K, et al. Identification of a novel circulating recombinant form (CRF33_01B)
disseminating widely among various risk populations in Kuala Lumpur, Malaysia. J Acquir Immune Defic Syndr
2006;43(5):523-529.
232. Tee KK, Pon CK, Kamarulzaman A, et al. Emergence of HIV-1 CRF01_AE/B unique recombinant forms in
Kuala Lumpur, Malaysia. AIDS 2005;19(2):119-126.
233. Tee KK, Saw TL, Pon CK, et al. The evolving molecular epidemiology of HIV type 1 among injecting drug
users (IDUs) in Malaysia. AIDS Res Hum Retroviruses 2005;21(12):1046-1050.
234. Tee KK, Takebe Y, Kamarulzaman A. Emerging and re-emerging viruses in Malaysia, 1997-2007. Int J Infect
Dis 2009;13(3):307-318.
235. Tee Y, Huang M. Knowledge of HIV/AIDS and attitudes towards people living with HIV among the general
staff of a public university in Malaysia. SAHARA J 2009;6(4):179-187.
236. Tengku Saifudin TI, Lee C. HIV associated opportunistic pneumonias. Med J Malaysia 2011;66(1):76-82
http://www.e-mjm.org/2011/v66n1/HIV.pdf.
237. Thana Sehgaran S, Puvaneswaris S, Abdul Razak K, et al. Epidemiology of HIV/AIDS in Perak Darul Ridzuan.
IMR Quarterly Bulletin 2003;(53):19-30
http://ilmusvr.imr.gov.my/bulletin/Bulletin%20Jan%202003.pdf.
238. Todd CS, Nassiramanesh B, Stanekzai MR, et al. Emerging HIV epidemics in Muslim countries: assessment of
different cultural responses to harm reduction and implications for HIV control. Curr HIV/AIDS Rep
2007;4(4):151-157.
239. Townsend D. Prisoners with HIV/AIDS: a participatory learning and action initiative in Malaysia. Trop Doct
2001;31(1):8-10.
240. TREAT Asia Pediatric HIV Observational Database (TApHOD), International Epidemiologic Databases to
Evaluate AIDS (IeDEA) Southern Africa Paediatric Group. A biregional survey and review of first-line treatment
failure and second-line paediatric antiretroviral access and use in Asia and southern Africa. J Int AIDS Soc
2011;14:7-2652-14-7.
241. Tung MY, Lee MHG, Ng CG, et al. Identifying depression among the human immunodeficiency virus (HIV)
patients in University Malaya Medical Centre, Kuala Lumpur, Malaysia. ASEAN Journal of Psychiatry
2009;10(2):135-147
http://www.aseanjournalofpsychiatry.org/pdf/2ASEAN_4_Ng.pdf.
242. Velaiutham S, Abdul Razak M, Khatijah B. Characteristics of pulmonary tuberculosis in HIV seropositive
patients in Chest Clinic, Penang Hospital. Malaysian Journal of Pharmaceutical Sciences 2004;2(2):31-31
http://myais.fsktm.um.edu.my/6863/1/characteristics_vol2_no2_(31)2004.pdf.
243. Vicknasingam B, Narayanan S, Navaratnam V. Prevalence rates and risk factors for hepatitis C among drug
users not in treatment in Malaysia. Drug Alcohol Rev 2009;28(4):447-454.
244. Vicknasingam B, Narayanan S, Navaratnam V. The relative risk of HIV among IDUs not in treatment in
Malaysia. AIDS Care 2009;21(8):984-991.
245. Vickneswari A. An evaluation of the time interval between awareness of risk and testing and between
testing positive and obtaining treatment in a sample of HIV infected patients in Kuala Lumpur. 2002;.
246. Vinothini A, Khoo EM, Adeeba K. Knowledge of HIV/AIDS among pregnant women in an urban health clinic a preliminary study. Family Physician 2005;13(1):10-15.
247. Wan MZ, Syed Hatim N, Naing NN. Characteristics Of HIV-Infected Tuberculosis Patients In Kota Bharu
Hospital, Kelantan From 1998 To 2001. Malaysian Journal of Pharmaceutical Sciences 2004;2(2):20-20
http://myais.fsktm.um.edu.my/6862/1/character_vol2_no2_(20)2004.pdf.
248. Wang B, Lau KA, Ong LY, et al. Complex patterns of the HIV-1 epidemic in Kuala Lumpur, Malaysia: evidence
for expansion of circulating recombinant form CRF33_01B and detection of multiple other recombinants.
Virology 2007;367(2):288-297.
249. Wickersham JA, Zahari MM, Azar MM, et al. Methadone dose at the time of release from prison
significantly influences retention in treatment: Implications from a pilot study of HIV-infected prisoners
transitioning to the community in Malaysia. Drug Alcohol Depend 2013;132(1-2):378-382.
250. Wolfe D, Carrieri MP, Shepard D. Treatment and care for injecting drug users with HIV infection: a review of
barriers and ways forward. Lancet 2010;376(9738):355-366.
251. Wong AR, Rasool AH, Abidin NZ, et al. Sildenafil as treatment for Human Immunodeficiency Virus-related
pulmonary hypertension in a child. J Paediatr Child Health 2006;42(3):147-148.
252. Wong LP. Prevalence and factors associated with HIV/AIDS-related stigma and discriminatory attitudes: A
cross-sectional nationwide study. Prev Med 2013;57 Suppl:S60-3.
253. Wong LP. Multi-ethnic perspective of uptake of HIV testing and HIV-related stigma: A cross-sectional
population-based study. AIDS Care 2013;.
254. Wong LP, Chin CK, Low WY, et al. HIV/AIDS-related knowledge among Malaysian young adults: findings
from a nationwide survey. Medscape J Med 2008;10(6):148.
255. Wong LP, Syuhada AR. Stigmatization and discrimination towards people living with or affected by HIV/AIDS
by the general public in Malaysia. Southeast Asian J Trop Med Public Health 2011;42(5):1119-1129.
256. Zahariyah Y, Rohani I, Shahrul Bariyah A, et al. A review of HIV antenatal screening programme in seleted
district in Kedah (1999-2002). IMR Quarterly Bulletin 2003;(55):39-43
http://ilmusvr.imr.gov.my/bulletin/Bulletin%20July%20Oct%202003.pdf.
257. Zaidah AR, Chan YY, Asma HS, et al. Detection of Cryptosporidium parvum in HIV-infected patients in
Malaysia using a molecular approach. Southeast Asian J Trop Med Public Health 2008;39(3):511-516.